• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用体细胞突变和拷贝数异常进行乳腺癌转移进展的系统进化分析。

Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations.

机构信息

Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000 Brussels, Belgium.

Laboratory of Translational Genetics, Vesalius Research Center, VIB, Campus Gasthuisberg, O&N IV Herestraat 49, 3000 Leuven, Belgium.

出版信息

Nat Commun. 2017 Apr 20;8:14944. doi: 10.1038/ncomms14944.

DOI:10.1038/ncomms14944
PMID:28429735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5474888/
Abstract

Several studies using genome-wide molecular techniques have reported various degrees of genetic heterogeneity between primary tumours and their distant metastases. However, it has been difficult to discern patterns of dissemination owing to the limited number of patients and available metastases. Here, we use phylogenetic techniques on data generated using whole-exome sequencing and copy number profiling of primary and multiple-matched metastatic tumours from ten autopsied patients to infer the evolutionary history of breast cancer progression. We observed two modes of disease progression. In some patients, all distant metastases cluster on a branch separate from their primary lesion. Clonal frequency analyses of somatic mutations show that the metastases have a monoclonal origin and descend from a common 'metastatic precursor'. Alternatively, multiple metastatic lesions are seeded from different clones present within the primary tumour. We further show that a metastasis can be horizontally cross-seeded. These findings provide insights into breast cancer dissemination.

摘要

使用全外显子测序和拷贝数分析对十名尸检患者的原发和多个匹配转移瘤进行分析后,我们利用系统发生技术推断了乳腺癌进展的进化史。我们观察到两种疾病进展模式。在一些患者中,所有远处转移灶都聚集在与其原发灶分开的分支上。体细胞突变的克隆频率分析表明,转移灶具有单克隆起源,来自一个共同的“转移前体”。或者,多个转移病灶是由原发肿瘤内的不同克隆播种而来。我们进一步表明转移灶可以水平交叉播种。这些发现为乳腺癌的扩散提供了新的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a524/5474888/972616b93c29/ncomms14944-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a524/5474888/5f0509ecbe7e/ncomms14944-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a524/5474888/6d4228cf03b5/ncomms14944-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a524/5474888/96057063ac8a/ncomms14944-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a524/5474888/fac080144f5b/ncomms14944-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a524/5474888/b172d4897080/ncomms14944-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a524/5474888/dc8c70a43e71/ncomms14944-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a524/5474888/972616b93c29/ncomms14944-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a524/5474888/5f0509ecbe7e/ncomms14944-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a524/5474888/6d4228cf03b5/ncomms14944-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a524/5474888/96057063ac8a/ncomms14944-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a524/5474888/fac080144f5b/ncomms14944-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a524/5474888/b172d4897080/ncomms14944-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a524/5474888/dc8c70a43e71/ncomms14944-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a524/5474888/972616b93c29/ncomms14944-f7.jpg

相似文献

1
Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations.利用体细胞突变和拷贝数异常进行乳腺癌转移进展的系统进化分析。
Nat Commun. 2017 Apr 20;8:14944. doi: 10.1038/ncomms14944.
2
Mutational profiles of breast cancer metastases from a rapid autopsy series reveal multiple evolutionary trajectories.乳腺癌转移快速尸检系列的突变特征揭示了多种进化轨迹。
JCI Insight. 2017 Dec 21;2(24):96896. doi: 10.1172/jci.insight.96896.
3
Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs).原发性乳腺癌及其配对转移病灶的外显子组测序揭示了 A-激酶锚定蛋白家族(AKAPs)中富含转移的突变。
BMC Cancer. 2018 Feb 12;18(1):174. doi: 10.1186/s12885-018-4021-6.
4
Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.治疗初发同步性原发性乳腺癌及其转移灶的遗传异质性。
Clin Cancer Res. 2017 Aug 1;23(15):4402-4415. doi: 10.1158/1078-0432.CCR-16-3115. Epub 2017 Mar 28.
5
A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer.循环肿瘤细胞与单一转移活检中外显子测序在乳腺癌中应用的可行性初步研究。
Int J Mol Sci. 2020 Jul 8;21(14):4826. doi: 10.3390/ijms21144826.
6
Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma to Invasive Ductal Carcinoma.非低级别导管癌进展为浸润性导管癌的全外显子组测序分析。
Clin Cancer Res. 2020 Jul 15;26(14):3682-3693. doi: 10.1158/1078-0432.CCR-19-2563. Epub 2020 Mar 27.
7
Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity.基于肿瘤内遗传异质性的原发性和转移性结直肠癌的亚克隆基因组结构。
Clin Cancer Res. 2015 Oct 1;21(19):4461-72. doi: 10.1158/1078-0432.CCR-14-2413. Epub 2015 May 15.
8
Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis.从癌前阶段到异时性转移的乳腺癌进展过程中的克隆扩增和线性基因组进化。
Oncotarget. 2015 Mar 20;6(8):5634-49. doi: 10.18632/oncotarget.3111.
9
Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.结直肠癌肿瘤演进过程中的基因组改变:全外显子组测序对原发肿瘤和同步肝转移瘤的差异追踪。
BMC Cancer. 2018 Jul 20;18(1):752. doi: 10.1186/s12885-018-4639-4.
10
Metastatic progression of breast cancer: insights from 50 years of autopsies.乳腺癌转移进展:50 年尸检研究的新视角。
J Pathol. 2014 Jan;232(1):23-31. doi: 10.1002/path.4288.

引用本文的文献

1
Clinical applications of circulating tumor cells in metastasis and therapy.循环肿瘤细胞在转移和治疗中的临床应用
J Hematol Oncol. 2025 Aug 22;18(1):80. doi: 10.1186/s13045-025-01733-y.
2
The role of long non-coding RNAs in lung cancer metastasis: Molecular mechanisms, pathogenesis and clinical implications.长链非编码RNA在肺癌转移中的作用:分子机制、发病机制及临床意义
Clin Transl Med. 2025 Aug;15(8):e70429. doi: 10.1002/ctm2.70429.
3
Genome-level selection in tumors as a universal marker of resistance to therapy.肿瘤中的基因组水平选择作为治疗抗性的通用标志物。

本文引用的文献

1
Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.血浆 ESR1 突变与雌激素受体阳性晚期乳腺癌的治疗。
J Clin Oncol. 2016 Sep 1;34(25):2961-8. doi: 10.1200/JCO.2016.67.3061. Epub 2016 Jun 6.
2
Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer.高级别浆液性卵巢癌中克隆扩散和腹腔内混合的不同模式。
Nat Genet. 2016 Jul;48(7):758-67. doi: 10.1038/ng.3573. Epub 2016 May 16.
3
Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant.
Nat Commun. 2025 Jul 16;16(1):6535. doi: 10.1038/s41467-025-61709-x.
4
Extrachromosomal DNA: shaping the evolutionary dynamics of cancer.染色体外DNA:塑造癌症的进化动力学
Trends Cancer. 2025 Jul 9. doi: 10.1016/j.trecan.2025.06.004.
5
Single-Cell Analysis Reveals that Vitamin C Inhibits Bone Metastasis of Renal Cancer via Cell Cycle Arrest and Microenvironment Remodeling.单细胞分析表明,维生素C通过细胞周期阻滞和微环境重塑抑制肾癌的骨转移。
Adv Sci (Weinh). 2025 Aug;12(30):e01011. doi: 10.1002/advs.202501011. Epub 2025 May 28.
6
Identification of key pathways and molecular players potentially involved in endometrial cancer metastasis through integrated bioinformatics analyses.通过综合生物信息学分析鉴定可能参与子宫内膜癌转移的关键途径和分子参与者。
Bioimpacts. 2024 Jun 26;15:30222. doi: 10.34172/bi.30222. eCollection 2025.
7
Molecular Underpinnings of Brain Metastases.脑转移瘤的分子基础
Int J Mol Sci. 2025 Mar 5;26(5):2307. doi: 10.3390/ijms26052307.
8
Integrating model systems and genomic insights to decipher mechanisms of cancer metastasis.整合模型系统与基因组学见解以破译癌症转移机制。
Nat Rev Genet. 2025 Mar 10. doi: 10.1038/s41576-025-00825-2.
9
Invasion and metastasis in cancer: molecular insights and therapeutic targets.癌症中的侵袭与转移:分子见解与治疗靶点
Signal Transduct Target Ther. 2025 Feb 21;10(1):57. doi: 10.1038/s41392-025-02148-4.
10
SHCBP1 is a novel regulator of PLK1 phosphorylation and promotes prostate cancer bone metastasis.SHCBP1是PLK1磷酸化的新型调节因子,并促进前列腺癌骨转移。
MedComm (2020). 2025 Feb 13;6(2):e70082. doi: 10.1002/mco2.70082. eCollection 2025 Feb.
接受氟维司群治疗的 ER 阳性转移性乳腺癌患者中 ESR1 突变的异质性和临床意义。
Nat Commun. 2016 May 13;7:11579. doi: 10.1038/ncomms11579.
4
Early and multiple origins of metastatic lineages within primary tumors.原发性肿瘤内转移谱系的早期和多源性起源。
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2140-5. doi: 10.1073/pnas.1525677113. Epub 2016 Feb 8.
5
Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer.循环肿瘤DNA中ESR1突变分析显示转移性乳腺癌治疗期间的演变。
Sci Transl Med. 2015 Nov 11;7(313):313ra182. doi: 10.1126/scitranslmed.aac7551.
6
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer.利用循环肿瘤DNA对一例转移性乳腺癌的多灶性克隆进化进行特征分析。
Nat Commun. 2015 Nov 4;6:8760. doi: 10.1038/ncomms9760.
7
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.脑转移瘤的基因组特征揭示了分支进化和潜在治疗靶点。
Cancer Discov. 2015 Nov;5(11):1164-1177. doi: 10.1158/2159-8290.CD-15-0369. Epub 2015 Sep 26.
8
Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.局部区域治疗与转移性乳腺癌中肿瘤原发灶不治疗的比较:一项开放标签随机对照试验。
Lancet Oncol. 2015 Oct;16(13):1380-8. doi: 10.1016/S1470-2045(15)00135-7. Epub 2015 Sep 9.
9
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.循环肿瘤 DNA 中的突变追踪可预测早期乳腺癌的复发。
Sci Transl Med. 2015 Aug 26;7(302):302ra133. doi: 10.1126/scitranslmed.aab0021.
10
Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing.对侧乳腺癌可能代表首个原发性肿瘤的转移扩散:利用新一代全基因组测序确定对侧乳腺癌之间的克隆关系。
Breast Cancer Res. 2015 Aug 5;17(1):102. doi: 10.1186/s13058-015-0608-x.